SCHEDULE: Northstrive Fund II LP, Braeden Lichti Disclose enVVeno Medical Stake

Northstrive Fund II LP and Braeden Lichti have disclosed beneficial ownership of enVVeno Medical Corp common stock, with Lichti holding a 5.05% stake.

Summary

• Northstrive Fund II LP and Braeden Lichti have filed a Schedule 13G, reporting their beneficial ownership in enVVeno Medical Corp.
• Braeden Lichti, as an individual, beneficially owns 33,151 shares of enVVeno Medical Corp common stock, representing 5.05% of the outstanding class.
• Northstrive Fund II LP beneficially owns 20,129 shares, representing 3.07% of the outstanding class.
• Braeden Lichti is the Manager of Northstrive Fund II LP.
• The percentage ownership is calculated based on 655,606 shares of enVVeno Medical Corporation's common stock outstanding as of January 20, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, as it indicates a new significant investor has taken a stake in enVVeno Medical Corp, which can be interpreted as a vote of confidence.

Positives

• Increased transparency regarding significant ownership stakes in enVVeno Medical Corp.
• A new beneficial ownership disclosure by an individual and a fund may signal confidence in the company.

Risks

• No specific risks to the issuer are mentioned in this beneficial ownership report.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that beneficial ownership filings like this provide transparency into significant investor positions, which can sometimes precede further investment or strategic engagement, particularly in the medical device sector where long-term investment is common.

Stakeholder Impact

• Shareholders: Increased transparency regarding significant ownership, potentially signaling investor confidence.

Key Dates

Recommendation

This filing is a disclosure of beneficial ownership, not a performance report or strategic announcement. While a new significant investor can be a positive signal, it does not provide enough information to warrant a 'buy' or 'sell' recommendation. Investors should hold and monitor future developments and the company's operational performance.

Keywords

enVVeno Medical Corp, Northstrive Fund II LP, Braeden Lichti, Schedule 13G, beneficial ownership, common stock, medical devices, investment, institutional ownership